125 related articles for article (PubMed ID: 10378712)
1. Type IX collagen immunoreactive peptides in synovial fluids from arthritis patients.
Wotton SF; Dieppe PA; Duance VC
Rheumatology (Oxford); 1999 Apr; 38(4):338-45. PubMed ID: 10378712
[TBL] [Abstract][Full Text] [Related]
2. IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen-anticollagen immune complexes in synovial fluid.
Clague RB; Moore LJ
Arthritis Rheum; 1984 Dec; 27(12):1370-7. PubMed ID: 6095870
[TBL] [Abstract][Full Text] [Related]
3. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis.
Trinder PK; Maeurer MJ; Brackertz D; Loos M
Immunology; 1996 Mar; 87(3):355-61. PubMed ID: 8778019
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay.
Menzel J; Steffen C; Kolarz G; Kojer M; Smolen J
Arthritis Rheum; 1978 Mar; 21(2):243-8. PubMed ID: 637891
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody patterns in synovial fluids from patients with rheumatoid arthritis or other arthritic lesions.
Lettesjö H; Nordström E; Ström H; Möller E
Scand J Immunol; 1998 Sep; 48(3):293-9. PubMed ID: 9743216
[TBL] [Abstract][Full Text] [Related]
6. Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids.
Trinder PK; Hickling TP; Sim RB; Brackertz D; Loos M; Maeurer MJ
Clin Exp Immunol; 2000 Apr; 120(1):183-7. PubMed ID: 10759781
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis.
Kaufmann J; Mueller A; Voigt A; Carl HD; Gursche A; Zacher J; Stein G; Hein G
Rheumatology (Oxford); 2003 Feb; 42(2):314-20. PubMed ID: 12595629
[TBL] [Abstract][Full Text] [Related]
8. Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients.
Sawada T; Kanzaki T; Hashimoto S; Suzuki A; Yamada R; Odawara M; Yamamoto K
Clin Exp Rheumatol; 2009; 27(6):989-92. PubMed ID: 20149318
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen.
Heinz HP; Brackertz D; Loos M
FEBS Lett; 1988 Feb; 228(2):332-6. PubMed ID: 2830144
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M
Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081
[TBL] [Abstract][Full Text] [Related]
11. Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis.
Hermann E; Fleischer B; Mayet WJ; Poralla T; Meyer zum Büschenfelde KH
Clin Exp Rheumatol; 1989; 7(4):411-4. PubMed ID: 2591114
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of antibodies to collagen and of collagen-anticollagen immune complexes in rheumatoid arthritis synovial fluids.
Menzel J; Steffen C; Kolarz G; Eberal G; Frank O; Thumb N
Ann Rheum Dis; 1975 Oct; 35(5):446-50. PubMed ID: 185972
[TBL] [Abstract][Full Text] [Related]
13. [Association between histopathologic type II synovitis and increased amounts of pyridinoline in synovial tissue samples in rheumatoid arthritis].
Wernicke D; Voigt A; Müller A; Schmidt WA; Stiehl P; Hein G
Z Rheumatol; 2008 May; 67(3):225-31. PubMed ID: 18369645
[TBL] [Abstract][Full Text] [Related]
14. 5'-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients.
Johnson SM; Patel S; Bruckner FE; Collins DA
Rheumatology (Oxford); 1999 May; 38(5):391-6. PubMed ID: 10371274
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to human native and denatured collagens in synovial fluids of patients with rheumatoid arthritis.
Andriopoulos NA; Mestecky J; Miller EJ; Bennett JC
Clin Immunol Immunopathol; 1976 Sep; 6(2):209-12. PubMed ID: 61086
[No Abstract] [Full Text] [Related]
16. Anti-type II collagen antibody in naturally occurring canine joint diseases.
Bari AS; Carter SD; Bell SC; Morgan K; Bennett D
Br J Rheumatol; 1989 Dec; 28(6):480-6. PubMed ID: 2590800
[TBL] [Abstract][Full Text] [Related]
17. Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis.
Alwan WH; Dieppe PA; Elson CJ; Bradfield JW
Ann Rheum Dis; 1988 Mar; 47(3):198-205. PubMed ID: 3258503
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis.
Sinz A; Bantscheff M; Mikkat S; Ringel B; Drynda S; Kekow J; Thiesen HJ; Glocker MO
Electrophoresis; 2002 Sep; 23(19):3445-56. PubMed ID: 12373775
[TBL] [Abstract][Full Text] [Related]
19. Serum and synovial fluid antibodies to collagen in rheumatic diseases: a review.
Verbruggen LA; Geerts A; Wisse E; Lapiere C
Clin Rheumatol; 1986 Dec; 5(4):440-4. PubMed ID: 3816091
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis.
Andriopoulos NA; Mestecky J; Wright GP; Miller EJ
Immunochemistry; 1976 Aug; 13(8):709-12. PubMed ID: 965038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
